Telephone-delivered incentives for encouraging individuals receiving opiate treatment to attend their pharmacy to take their medication: testing the feasibility of undertaking a future trial

Not Applicable

• Conditions: Individuals receiving opioid agonist treatment; Mental and Behavioural Disorders

• Registration Number: ISRCTN33965312
• Lead Sponsor: King's College London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-26
• Last Update Posted: 19 February 2024
• Study Completion: 2024-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

The eligibility criteria for enrolling service user participants will include:
1. Receiving supervised OAT (methadone or buprenorphine) 6 days a week
2. Missed three doses of OAT and re-presenting at drug clinic for dose assessment/re-start
3. Aged =18 years at time of enrolment
4. Attending a participating pharmacy
5. Owns a mobile phone
6. Able to read English and not require the service of an interpreter
7. Willing and able to provide informed consent.

The criteria for enrolling community pharmacies will include:
1. The pharmacy is currently providing supervised consumption of oral methadone or buprenorphine to the patients at the drug clinic
2. Pharmacists are willing and able to provide six days of supervised consumption of oral methadone or buprenorphine
3. The pharmacy has a consultation room on the premises or a separate designated area on the dispensing counter where participants can consume their oral methadone or buprenorphine under supervision
4. The pharmacy is willing and able to provide dispensing records for participants over the 12-week intervention period

Exclusion Criteria

Patients who cannot read English AND require the service of an interpreter to understand a brief oral description of the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified